SCHEMBL7410043

SCHEMBL7410043

CC#CC=CCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11241536 0.73
SCHEMBL9249993 0.72
SCHEMBL9249987 0.72
SCHEMBL7037053 0.71
SCHEMBL12389699 0.71
SCHEMBL2770182 0.70 LMNA (0.37)
Hydrochloric Acid SCHEMBL9455191 0.70
SCHEMBL2770183 0.70 LMNA (0.37)
Hydrochloric Acid SCHEMBL9455189 0.70
SCHEMBL9609558 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0573498-B1 ALIPHATIC PROPARGYLAMINES AS SELECTIVE MAO-B INHIBITORS AND AS NEUROPROTECTIVE AGENTS UNIV SASKATCHEWAN (CA) 1998-11-18 EP disclosed
US-5508311-A Aliphatic propargylamines as selective MAO-B inhibitors and as neuroprotective agents UNIVERSITY OF SASKATCHEWAN (CA) 1996-04-16 US disclosed
EP-0573498-A1 ALIPHATIC PROPARGYLAMINES AS SELECTIVE MAO-B INHIBITORS AND AS NEUROPROTECTIVE AGENTS UNIVERSITY OF SASKATCHEWAN (CA) 1993-12-15 EP disclosed
US-5169868-A Antidepressants, enzyme inhibitors; alleviating parkinsonism, alzheimer's disease UNIVERSITY OF SASKATCHEWAN (CA) 1992-12-08 US disclosed
WO-1992015551-A1 ALIPHATIC PROPARGYLAMINES AS SELECTIVE MAO-B INHIBITORS AND AS NEUROPROTECTIVE AGENTS UNIVERSITY OF SASKATCHEWAN (CA) 1992-09-17 WO disclosed